C-Council Directory
Miranda Lam
Chief Legal Officer & Senior Director, Business Development AcuitasBiography
Acuitas is the premier LNP (lipid nanoparticle) technology provider enabling our partners to advance new therapeutics to address unmet clinical needs. We have developed a broad IP portfolio focussed on the use of LNP technology for nucleic acid therapeutics. This portfolio primarily encompasses novel compositions of matter but also includes novel uses of nucleic acids therapeutics.